Wordt geladen...
4CPS-105 Blinatumomab for the treatment of the relapse b-precursor acute lymphoblastic leukaemia in a paediatric patient: a case report
BACKGROUND: Paediatric patients with relapsed B-precursor acute lymphoblastic leukaemia (ALL) after haematopoietic stem cell transplantation (HSCT) have a poor prognosis and need to achieve another haematologic remission or very low or negative minimal residual disease (MRD) before proceeding to a s...
Bewaard in:
| Gepubliceerd in: | Eur J Hosp Pharm |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Group
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535816/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.196 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|